SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma

    Naumann RW (1), Hollebecque A (2), Meyer T (3), Devlin MJ (3), Oaknin A (4), Kerger J (5), López-Picazo JM (6), Machiels JP (7), Delord JP (8), Evans TRJ (9), Boni V (10), Calvo E (10), Topalian SL (11), Chen T (12), Soumaoro I (12), Li B (12), Gu J (12), Zwirtes R (12), Moore KN (13).

    (1) Levine Cancer Institute, Atrium Health, Charlotte, NC.
    (2) Gustave Roussy, Villejuif, France.
    (3) UCL Cancer Institute, London, United Kingdom.
    (4) Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
    (5) Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
    (6) Clínica Universidad de Navarra, Navarra, Spain.
    (7) Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (IREC, Pole MIRO), UCLouvain, Brussels, Belgium.
    (8) IUCT-Oncopole, Toulouse, France.
    (9) University of Glasgow, Glasgow, United Kingdom.
    (10) START Madrid Centro Integral Oncológico Clara Campal, Madrid, Spain.
    (11) Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy and Kimmel Cancer Center, Baltimore, MD.
    (12) Bristol-Myers Squibb, Princeton, NJ.
    (13) Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, and Sarah Cannon Research Institute, Nashville, TN.

    Journal of Clinical Oncology 05 SEPTEMBER 2019

  • Social and health care needs in patients with hereditary fructose intolerance in Spain

    Izquierdo-García E (1), Escobar-Rodríguez I (2), Moreno-Villares JM (3), Iglesias-Peinado I (4). (1) Servicio de Farmacia, Hospital Universitario Infanta Leonor, Madrid, España; Asociación de Afectados por Intolerancia Hereditaria a la Fructosa (AAIHF), España.
    (2) Servicio de Farmacia, Hospital Universitario Infanta Leonor, Madrid, España.
    (3) Servicio de Pediatría, Clínica Universidad de Navarra, Madrid, España.
    (4) Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, España.

    Endocrinología, diabetes y nutrición 07 AUGUST 2019

  • Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

    Munárriz J (1), Reynés G (2,3), Sánchez-Lorenzo L (4), Esteban E (5), Basterretxea L (6), de Avila-Lizárraga L (7), Climent MA (8), Juan-Fita MJ (8), Escoín C (9), Puente J (10), Cassinello J (11), Vázquez S (12), Chirivella I (13).

    (1) Department of Medical Oncology, Consorci Hospitalari Provincial de Castelló, Castelló, Spain.
    (2) Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
    (3) Scio. de Oncología Médica, Hospital Universitario y Politécnico La Fe, Avda. Fernando Abril Martorell nº 106, 46026, Valencia, Spain.
    (4) Clínica Universidad de Navarra, Campus Madrid, Madrid, Spain.
    (5) Hospital Universitario Central de Asturias, Oviedo, Spain.
    (6) Donostialdea ESI/OSI Donostialdea, Donostia, Unibertsitate Ospitalea/Hospital Universitario Donostia, Donostia, Spain.
    (7) Hospital San Pedro, Logroño, Spain.
    (8) Instituto Valenciano de Oncología, Valencia, Spain.
    (9) Hospital Universitario de La Ribera, Valencia, Spain.
    (10) Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
    (11) Hospital Universitario de Guadalajara, Guadalajara, Spain.
    (12) Hospital Universitario Lucus Augusti, Lugo, Spain.
    (13) Hospital Clínico Universitario de Valencia, Valencia, Spain.

    Cancer Chemotherapy Pharmacology 31 JULY 2019

  • Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications

    Marcos-Jubilar M (1), García Erce JA (2), Martínez-Calle N (3), Páramo JA (1), Martínez Virto A (4), Quintana-Díaz M (5)

    (1) Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Banco de Sangre y Tejidos de Navarra, Pamplona, Spain.
    (3) Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
    (4) Emergency Department, Hospital Universitario La Paz, Madrid, Spain.
    (5) Intensive Medicine, Hospital Universitario La Paz, Madrid, Spain.

    Transfusion Medicine 25 JULY 2019

  • Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

    Usmani SZ (1), Nahi H (2), Mateos MV (3), van de Donk NWCJ (4), Chari A (5), Kaufman JL (6), Moreau P (7), Oriol A (8), Plesner T (9), Benboubker L (10), Hellemans P (11), Masterson T (12), Clemens PL (13), Luo M (12), Liu K (14), San Miguel J (15)

    (1) Levine Cancer Institute/Atrium Health, United States
    (2) Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Sweden.
    (3) Department of Hematology, University Hospital of Salamanca7IBSAL, Spain.
    (4) Hematology, VU University Medical Center, Netherlands.
    (5) Mount Sinai Hospital, United States.
    (6) Hematology and Medical Oncology, Emory University Winship Cancer Institute, United States.
    (7) Department of Hematology, Centre Hospitalier Universitaire de Nantes, France.
    (8) Clinical Hematology, ICO - Hosp Germans Trias i Pujol, Spain.
    (9) Hematology, Vejle Hospital, Denmark.
    (10) Hematology & cell therapy, CHRU TOURS, France.
    (11) Janssen Research & Development, LLC, Belgium.
    (12) Janssen Research & Development, LLC, United States.
    (13) Janssen R&D, United States.
    (14) Biostatistics, Johnson & Johnson PRD, LLC, United States.
    (15) Clinica Universidad de Navarra, Universidad de Navarra, Spain.

    Blood 03 JULY 2019

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra